Search research articles
Contact Us
Filters
Showing results (631-640 of 932) with videos related to
Page
of 94
Sort By:
The Journal of Thoracic and Cardiovascular Surgery
|
January 3, 2007
Initial United States experience with the Paracor HeartNet myocardial constraint device for heart failure
Charles T Klodell, David C McGiffin, Barry K Rayburn, et al.
Journal of the American College of Cardiology
|
July 12, 2008
Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF program
Gregg C Fonarow, William T Abraham, Nancy M Albert, et al.
Heart Rhythm
|
November 29, 2021
The importance of early evaluation after cardiac resynchronization therapy to redefine response: Pooled individual patient analysis from 5 prospective studies
Eugene S Chung, Michael R Gold, William T Abraham, et al.
Journal of Cardiac Failure
|
November 13, 2007
Prospective evaluation of beta-blocker use at the time of hospital discharge as a heart failure performance measure: results from OPTIMIZE-HF
Gregg C Fonarow, William T Abraham, Nancy M Albert, et al.
Cardiology
|
January 1, 1995
Importance of angiotensin-converting enzyme in pulmonary hypertension
W T Abraham, M V Raynolds, B Gottschall, et al.
Journal of the American College of Cardiology
|
July 26, 2008
Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)
William T Abraham, Gregg C Fonarow, Nancy M Albert, et al.
The American Journal of Cardiology
|
November 26, 2008
Dosing of beta-blocker therapy before, during, and after hospitalization for heart failure (from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure)
Gregg C Fonarow, William T Abraham, Nancy M Albert, et al.
Circulation
|
February 22, 2017
Impact of Practice-Based Management of Pulmonary Artery Pressures in 2000 Patients Implanted With the CardioMEMS Sensor
J Thomas Heywood, Rita Jermyn, David Shavelle, et al.
Journal of Cardiac Failure
|
April 30, 2015
Rationale and Design of the Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Study (LAPTOP-HF)
Mathew S Maurer, Philip B Adamson, Maria Rosa Costanzo, et al.
Immunity
|
December 1, 1996
Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation
B A Binstadt, K M Brumbaugh, C J Dick, et al.
Page
of 94
Search research articles
Search
Showing results (631-640 of 932) with videos related to
Sort By:
Page
of 94
The Journal of Thoracic and Cardiovascular Surgery
|
January 3, 2007
Initial United States experience with the Paracor HeartNet myocardial constraint device for heart failure
Charles T Klodell, David C McGiffin, Barry K Rayburn, et al.
Journal of the American College of Cardiology
|
July 12, 2008
Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF program
Gregg C Fonarow, William T Abraham, Nancy M Albert, et al.
Heart Rhythm
|
November 29, 2021
The importance of early evaluation after cardiac resynchronization therapy to redefine response: Pooled individual patient analysis from 5 prospective studies
Eugene S Chung, Michael R Gold, William T Abraham, et al.
Journal of Cardiac Failure
|
November 13, 2007
Prospective evaluation of beta-blocker use at the time of hospital discharge as a heart failure performance measure: results from OPTIMIZE-HF
Gregg C Fonarow, William T Abraham, Nancy M Albert, et al.
Cardiology
|
January 1, 1995
Importance of angiotensin-converting enzyme in pulmonary hypertension
W T Abraham, M V Raynolds, B Gottschall, et al.
Journal of the American College of Cardiology
|
July 26, 2008
Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)
William T Abraham, Gregg C Fonarow, Nancy M Albert, et al.
The American Journal of Cardiology
|
November 26, 2008
Dosing of beta-blocker therapy before, during, and after hospitalization for heart failure (from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure)
Gregg C Fonarow, William T Abraham, Nancy M Albert, et al.
Circulation
|
February 22, 2017
Impact of Practice-Based Management of Pulmonary Artery Pressures in 2000 Patients Implanted With the CardioMEMS Sensor
J Thomas Heywood, Rita Jermyn, David Shavelle, et al.
Journal of Cardiac Failure
|
April 30, 2015
Rationale and Design of the Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Study (LAPTOP-HF)
Mathew S Maurer, Philip B Adamson, Maria Rosa Costanzo, et al.
Immunity
|
December 1, 1996
Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation
B A Binstadt, K M Brumbaugh, C J Dick, et al.
Page
of 94